Yunis Edmond J, Romero Viviana, Diaz-Giffero Felipe, Zuñiga Joaquin, Koka Prasad
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston MA.
J Stem Cells. 2007;2(4):237-248.
HIV infection and its outcome is complex because there is great heterogeneity not only in clinical presentation, incomplete clinical information of markers of immunodeficiency and in measurements of viral loads. Also, there many gene variants that control not only viral replication but immune responses to the virus; it has been difficult to study the role of the many AIDS restricting genes (ARGs) because their influence vary depending on the ethnicity of the populations studies and because the cost to follow infected individuals for many years. Nevertheless, at least genes of the major histocompatibility locus (MHC) such as HLA alleles have been informative to classify infected individuals following HIV infection; progression to AIDS and long-term-non-progressors (LTNP). For example, progressors could be defined as up to 5 years, up to 11 years or as we describe in this report up to 15 years from infection, and LTNP could be individuals with normal CD4+ T cell counts for more than 15 years with or without high viral loads. In this review, we emphasized that in the studies of ARGs the HLA alleles are important in LTNP; HLA-B alleles influencing the advantage to pathogens to produce immune defense mediated by CD8+ T cells (cognate immunuity). Our main point we make in this report is that contrary to recent reports claiming that this dominant effect was unlikely due to differences in NK activation through ligands such as HLA-Bw4 motif, we believe that cognate immunity as well as innate immunity conferred by NK cells are involved. The main problem is that HLA-Bw4 alleles can be classified according the aminoacid in position 80. Isoleucine determines LTNP, which is a ligand for 3DS1. Such alleles did not include HLA-B44. B13 and B27 which have threonine at that position. The authors have not considered the fact that in addition to the NK immunoglobulin receptors, NK receptors can be of the lectin like such as NKG2A/HLA-E to influence the HIV infection outcome. HLA-Bw4 as well as HLA-Bw6 alleles can be classified into those with threonine or methionine in the second position of their leader peptides. These leader peptides are ligands for NKG2A in which methionine influences the inhibitory role of NKG2A for killing infected targets. Functional studies have not been done as well as studies of these receptors in infected individuals. However, analyses of the leader peptides of HLA-B alleles in published reports, suggested that threonine in the second position can explain the importance of HLA-B57, B13, B44 as well as certain Bw6 alleles in LNTP. In addition, we analyzed the San Francisco database that was reported and found that the association of HLA-B alleles with LNTP or with progressors can be due to the presence of threonine or methionine in their second position. Therefore, studies of outcome of HIV infection should include not only mechanisms of cognate immunity mediated by peptides and CD8+ T cells but also, NK receptors of two types, NKG2A as well as 3DSI. We propose that the SCID mouse should be used to understand mechanisms mediated by many of the ARGs especially the importance of thymus derived cells as well as NK receptor interactions with their ligands in this experimental animal transplanted with human stem cells, thymus or NK cells obtained from individuals of known HLA genotypes.
HIV感染及其结果很复杂,因为不仅临床表现存在很大异质性,免疫缺陷标志物的临床信息不完整,而且病毒载量的测量也存在差异。此外,有许多基因变体不仅控制病毒复制,还控制对病毒的免疫反应;研究众多艾滋病限制基因(ARG)的作用一直很困难,因为它们的影响因所研究人群的种族而异,也因为跟踪感染个体多年的成本很高。然而,至少主要组织相容性位点(MHC)的基因,如HLA等位基因,对于对HIV感染后的个体进行分类、进展为艾滋病以及长期不进展者(LTNP)具有参考价值。例如,进展者可以定义为感染后长达5年、长达11年,或者如我们在本报告中所描述的长达15年,而LTNP可以是CD4 + T细胞计数正常超过15年的个体,无论病毒载量高低。在本综述中,我们强调在ARG研究中,HLA等位基因在LTNP中很重要;HLA - B等位基因影响病原体通过CD8 + T细胞介导产生免疫防御的优势(同源免疫)。我们在本报告中的主要观点是,与最近声称这种主导效应不太可能是由于通过诸如HLA - Bw4基序等配体激活NK细胞的差异的报告相反,我们认为同源免疫以及NK细胞赋予的固有免疫都参与其中。主要问题是HLA - Bw4等位基因可以根据第80位的氨基酸进行分类。异亮氨酸决定LTNP,它是3DS1的配体。这些等位基因不包括在该位置具有苏氨酸的HLA - B44、B13和B27。作者没有考虑到这样一个事实,即除了NK免疫球蛋白受体外,NK受体还可以是凝集素样的,如NKG2A/HLA - E,以影响HIV感染结果。HLA - Bw4以及HLA - Bw6等位基因可以根据其前导肽第二位的苏氨酸或蛋氨酸进行分类。这些前导肽是NKG2A的配体,其中蛋氨酸影响NKG2A对杀伤感染靶标的抑制作用。尚未对感染个体进行这些受体的功能研究以及相关研究。然而,对已发表报告中HLA - B等位基因前导肽的分析表明,第二位的苏氨酸可以解释HLA - B57、B13、B44以及某些Bw6等位基因在LNTP中的重要性。此外,我们分析了所报道的旧金山数据库,发现HLA - B等位基因与LNTP或进展者的关联可能是由于其第二位存在苏氨酸或蛋氨酸。因此,HIV感染结果的研究不仅应包括由肽和CD8 + T细胞介导的同源免疫机制,还应包括两种类型的NK受体,即NKG2A以及3DSI。我们建议使用SCID小鼠来了解许多ARG介导的机制,特别是胸腺来源细胞的重要性以及在移植了来自已知HLA基因型个体的人类干细胞、胸腺或NK细胞的这种实验动物中NK受体与其配体的相互作用。